sulfamonomethoxine has been researched along with Malaria in 3 studies
Sulfamonomethoxine: Long acting sulfonamide antibacterial agent.
Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-eight cases of vivax and 30 cases of falciparum malaria patients were treated with a combination of sulfamonomethoxine-pyrimethamine (MP tablet with 500 mg of sulfamonomethoxine and 25 mg of pyrimethamine) and the results were compared with those with chloroquine, Fansidar and quinine." | 7.67 | A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria. ( Ebisawa, I; Ohara, H, 1986) |
| "Sixty-eight cases of vivax and 30 cases of falciparum malaria patients were treated with a combination of sulfamonomethoxine-pyrimethamine (MP tablet with 500 mg of sulfamonomethoxine and 25 mg of pyrimethamine) and the results were compared with those with chloroquine, Fansidar and quinine." | 3.67 | A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria. ( Ebisawa, I; Ohara, H, 1986) |
| "A review of chloroquine and sulfa-antifol combination treated falciparum malaria patients revealed a high incidence of chloroquine-resistance, wither R1 or R2, in patients infected in Southeast Asia or Oceania." | 3.66 | Chemotherapy of falciparum malaria: regional differences in responsiveness to treatment. ( Ebisawa, I; Muto, T; Tanabe, S, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebisawa, I | 2 |
| Muto, T | 1 |
| Tanabe, S | 1 |
| Kumagai, Y | 1 |
| Kushimoto, K | 1 |
| Sawae, Y | 1 |
| Aoki, T | 1 |
| Moriyasu, M | 1 |
| Goya, N | 1 |
| Ohara, H | 1 |
3 other studies available for sulfamonomethoxine and Malaria
| Article | Year |
|---|---|
Chemotherapy of falciparum malaria: regional differences in responsiveness to treatment.
Topics: Adult; Africa, Central; Africa, Western; Asia, Southeastern; Chloroquine; Drug Resistance; Drug Ther | 1979 |
[Black water fever associated with quinine-MP therapy of a malaria patient].
Topics: Adult; Antimalarials; Blackwater Fever; Drug Combinations; Humans; Malaria; Male; Plasmodium falcipa | 1986 |
A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria.
Topics: Adolescent; Adult; Aged; Chloroquine; Drug Combinations; Female; Humans; Malaria; Male; Middle Aged; | 1986 |